Alrex; Bausch & Lomb, Pharmos; Treatment for seasonal allergic conjunctivitis, Approved March
1998
Cosopt; Merck; Treatment for glaucoma or ocular hypertension, Approved April 1998
Lotemax; Bausch & Lomb, Pharmos; Treatment for post-operative eye inflammation, Approved
March 1998
Salagen Tablets; MGI Pharma; Treatment for Sjogren's Syndrome, Approved February 1998
Viroptic; King Pharmaceuticals; Treatment for inflammation of the cornea in children due to herpes
simplex virus, Approved February 1998
Vitravene Injection; Isis Pharmaceuticals; Treatment for CMV in AIDS patients, Approved August
1998
Omidria (phenylephrine and ketorolac injection); Omeros; For use during eye surgery to
prevent intraoperative miosis and reduce post-operative pain, Approved June 2014
Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed
Pollens Allergen Extract); Greer Labs; For the treatment of grass pollen-induced allergic
rhinitis with or without conjunctivitis, Approved April 2014
Lucentis (ranibizumab injection); Genentech; For the treatment of diabetic macular edema,
Approved August 2012
Zioptan (tafluprost ophthalmic solution); Merck; For the treatment of elevated intraocular
pressure, Approved February 2012
Eylea (aflibercept); Regeneron Pharmaceuticals; For the treatment of neovascular (wet) agerelated macular degeneration, Approved November 2011
Acuvail (ketorolac tromethamine); Allergan; For the treatment of pain and inflammation
following cataract surgery., Approved July 2009
Bepreve (bepotastine besilate ophthalmic solution); Ista Pharmaceuticals; For the treatment
of itching associated with allergic conjunctivitis, Approved September 2009
Besivance (besifloxacin ophthalmic suspension); Bausch & Lomb; For the treatment of
bacterial conjunctivitis, Approved June 2009
Ozurdex (dexamethasone); Allergan; For the treatment of macular edema following branch
retinal vein occlusion or central retinal vein occlusion, Approved June 2009
Zirgan (ganciclovir ophthalmic gel); Sirion Therapeutics; For the treatment of acute herpetic
keratitis, Approved September 2009
Astepro (azelastine hydrochloride nasal spray); Meda Pharmaceuticals Inc; For the treatment
of seasonal and perennial allergic rhinitis, Approved October 2008
Durezol (difluprednate); Sirion Therapeutics; For the treatment of inflammation and pain
associated with ocular surgery, Approved June 2008
AzaSite (azithromycin); InSite Vision; For the treatment of bacterial conjunctivitis, Approved
April 2007
Lucentis (ranibizumab); Genentech; For the treatment of neovascular (wet) age related
macular degeneration, Approved June 2006
Macugen (pegaptanib); Pfizer / Eyetech Pharmaceuticals; For the treatment of wet agerelated macular degeneration., Approved December 2004
Restasis (cyclosporine ophthalmic emulsion); Allergan; For the treatment of low tear
production., December 2002
Travatan (travoprost ophthalmic solution); Alcon; For the reduction of elevated intraocular
pressure in patients with open-angle glaucoma or ocular hypertension, Approved March 2001
Valcyte (valganciclovir HCl); Roche; For the treatment of cytomegalovirus retinitis in patients
with AIDS, Approved March 2001
Betaxon; Alcon; For lowering IOP in patients with chronic open-angle glaucoma or ocular
hypertension, Approved February 2000
Rescula (unoprostone isopropyl ophthalmic solution) 0.15%; Ciba Vision; For the treatment
of open-angle glaucoma or ocular hypertension, Approved August 2000
Visudyne (verteporfin for injection); QLT; For the treatment of wet age-related macular
degeneration (wet AMD), Approved April 2000
ZADITOR; Ciba Vision; Treatment for the prevention of itching of the eye, Approved July
1999